ASX:RHT Resonance Health (RHT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Resonance Health Stock (ASX:RHT) 30 days 90 days 365 days Advanced Chart Get Resonance Health alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.57 million shsAverage VolumeN/AMarket Capitalization$28.50 millionP/E Ratio168.79Dividend Yield5.77%Price TargetN/AConsensus RatingN/A Company OverviewResonance Health Limited, a healthcare technology and services company, designs, develops, manufactures, and commercializes software-as-medical devices in the Asia Pacific, North America, Europe, the Middle East, and Africa. The company offers FerriScan, a non-invasive MRI based system for quantifying liver iron concentration (LIC); FerriSmart, an artificial intelligence (AI) assisted device for the automated real-time assessment of LIC; HepaFat-AI, an AI-trained device for the automated real-time multi-metric measurement of liver-fat; CardiacT2, a dual analysis service with FerriScan for assessing heart iron loading; HepaFat-Scan, a non-invasive MRI-based solution for the assessment of liver-fat in liver tissue; and LiverSmart, a non-invasive MRI-based multi-parametric device combining FerriSmart and HepaFat-AI into a consolidated report. It also provides quantitative imaging measurements and CRO services, such as quality-assured image analysis, project and data management, and issue resolution services; biomarkers, genomics, and laboratory analysis services, as well as works with third party pathology laboratories for blood/sample collection and for standard biochemical/lab safety assessments; design and protocol development, and project management and monitoring services; assessment of subject inclusion or exclusion, evaluating the safety profile of a new therapy, and supporting primary and secondary end-points demonstrating drug efficacy services; and phantoms for the MRI machines. The company serves clinicians for the management of human diseases; and pharmaceutical and therapeutic companies for their clinical trials. Resonance Health Limited was incorporated in 1987 and is headquartered in Burswood, Australia.Read More… Receive RHT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Resonance Health and its competitors with MarketBeat's FREE daily newsletter. Email Address RHT Stock News HeadlinesFall asleep fast with this one breathing technique proven to relax your whole bodyFebruary 7, 2025 | msn.comResonance Health Ltd.December 5, 2024 | wsj.com$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.February 24, 2025 | Stansberry Research (Ad)Guess which 2 ASX small-cap shares just rocketed 50%+ on big news!November 19, 2024 | msn.comHealth Check: Sonic Healthcare is cashed up and ready to boom as earnings improveNovember 18, 2024 | msn.comResonance Health Trading Halt Ahead of Major AnnouncementNovember 18, 2024 | msn.comBreast cancer awareness — a personal journey through early detection and treatmentNovember 11, 2024 | msn.comResonance Health Ltd Updates on Securities ConversionNovember 10, 2024 | markets.businessinsider.comSee More Headlines RHT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Resonance Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Resonance Health investors own include ZIP (Z1P), Vital Metals (VML), QX Resources (QXR) and DXN (DXN). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:RHT CUSIPN/A CIKN/A Webwww.resonancehealth.com Phone61 8 9286 5300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio168.79 Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,090,000.00 Net Margins1.97% Pretax MarginN/A Return on Equity1.63% Return on Assets-2.30% Debt Debt-to-Equity Ratio33.81 Current Ratio1.51 Quick Ratio9.76 Sales & Book Value Annual Sales$8.59 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow22.50 Book ValueA$0.02 per share Price / BookN/AMiscellaneous Outstanding Shares446,890,000Free FloatN/AMarket Cap$28.50 million OptionableNot Optionable Beta1.32 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (ASX:RHT) was last updated on 2/24/2025 by MarketBeat.com Staff From Our PartnersMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredA new coin is elbowing its way to the top of the crypto worldWith Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in FebruaryA little-known IRS loophole has been gaining serious attention... If you have a retirement account, you can...Premier Gold Co | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resonance Health Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Resonance Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.